Atlas Atomics has raised about $400 million in Series A financing at a valuation of roughly $1.9 billion, an unusually large round for a nuclear startup that remains largely out of public view. The company’s core wager is a heavy water reactor design that can run on natural uranium, potentially bypassing one of the industry’s biggest bottlenecks: fuel enrichment.
The financing places Atlas among the most highly valued private nuclear companies in the U.S. market, even though it has not publicly released a detailed reactor design. The scale of the raise signals how aggressively capital is flowing into advanced nuclear as investors search for long-duration power solutions tied to grid reliability, industrial demand and energy security.
Atlas’ strategy also stands out because it points toward a different path than many small modular reactor and microreactor developers, several of which depend on high-assay low-enriched uranium, or HALEU, a fuel category facing limited supply in the West.
Key Facts
- Atlas Atomics raised about $400 million in a Series A round at a valuation of roughly $1.9 billion.
- General Catalyst led the financing, with participation from Andreessen Horowitz.
- Vivek Ramaswamy is a cofounder and backer, while Kevin Gan is leading the company.
- Atlas was selected in the second round of the National Reactor Innovation Center’s Nuclear Energy Launch Pad.
- Investors have poured $4.6 billion into U.S. nuclear startups in 2026, underscoring a broad funding surge across the sector.
Atlas Atomics heavy water reactor
Atlas Atomics is pursuing a heavy water reactor, a technology family best known through Canada’s CANDU fleet and India’s pressurized heavy water reactors. The defining appeal is that heavy water, or deuterium oxide, is highly efficient at slowing neutrons while absorbing relatively few of them. That means the reactor can potentially operate on natural uranium rather than enriched uranium.
For developers, that distinction matters. Much of the next generation nuclear field is trying to secure specialized fuel that is scarce, expensive and exposed to geopolitical risk. A reactor that avoids enrichment could reduce dependence on a constrained supply chain and shorten one of the longest critical paths to commercialization. Atlas has also signaled interest in applications beyond electricity, including medical and industrial isotopes and nuclear fuel recycling, broadening the addressable market if the design advances.
The company appears to be looking toward Utah for an initial foothold. That aligns with a broader push among western U.S. states to attract advanced energy infrastructure that can support data centers, industrial facilities and population growth while meeting increasingly strict reliability and emissions goals.
A reactor that can skip enrichment is not a shortcut to deployment, but it could reshape where the real bottlenecks sit in advanced nuclear.
Why the fuel supply chain still matters
Heavy water reactors solve one problem but create others. The U.S. does not have a commercial fabrication line for CANDU-style natural uranium fuel bundles, so Atlas would likely need to help build that capability or secure dependable manufacturing through partners. That is not unique in advanced nuclear; several rival developers are also working to establish first-of-a-kind fuel supply chains for metallic, TRISO or other specialized fuels.
Heavy water itself is another challenge. Producing deuterium oxide at scale is energy intensive and costly, and the U.S. currently lacks commercial domestic output. Existing North American supply is concentrated in Canada, meaning Atlas may need to import material or support new production capacity before any commercial reactor can start operations. In other words, avoiding enrichment does not eliminate supply risk; it shifts it into different parts of the value chain.
Implications for Investors
The Atlas financing is a clear sign that nuclear investing has moved into a new phase. Venture and growth capital are no longer just funding reactor concepts; they are backing full-stack energy platforms that may include fuel, services, isotope production and long-term infrastructure plays. That can expand upside, but it also raises execution risk because success depends on manufacturing, licensing, construction and commodity inputs all advancing in parallel.
Investors should also watch the competitive landscape. Canada’s established heavy water ecosystem could become a meaningful advantage for incumbents and licensors with decades of operating experience. AtkinsRealis has already submitted a notice of intent to begin licensing CANDU technology in the U.S., creating the prospect that Atlas will compete not only with startup peers but with a mature reactor lineage that has a long operating history and a known refurbishment track record.
For public-market investors, the broader takeaway extends beyond Atlas itself. The sector’s capital inflows suggest growing confidence that advanced nuclear will play a larger role in U.S. power policy through 2050, especially after the Trump administration’s executive order targeting a quadrupling of domestic nuclear capacity by that year. Companies tied to uranium conversion, fuel fabrication, heavy engineering, isotope supply, grid equipment and permitting support could all see secondary benefits if even a portion of these projects move from concept to construction.
The next milestones will be more important than the headline valuation: design disclosure, regulatory pathway, fuel strategy and site development. If Atlas can show progress on those fronts, its heavy water reactor bet may become a significant test case for whether avoiding enrichment offers a faster route to commercial nuclear deployment in the U.S.